Latest Articles

Publication Date
Merck's Keytruda plus chemo comes up short as post-surgery therapy in newly diagnosed endometrial cancer - FiercePharma

Merck's Keytruda plus chemo comes up short as post-surgery therapy in newly diagnosed endometrial cancer FiercePharma

Published: May 9, 2024, 7 a.m.
Beyond the surface: Does stage I-II endometriosis impact fertility? Exploring the challenges of mild disease.

Endometriosis is one of the most common gynecologic conditions that women face throughout their lives. Despite advances in technology, diagnosis and treatment of this relapsing and remitting condition is still …

Published: May 9, 2024, midnight
‘My husband had to sign permission for my hysterectomy when I was 30’ - The Telegraph

‘My husband had to sign permission for my hysterectomy when I was 30’ The Telegraph

Published: May 6, 2024, 7 a.m.
GLAMOUR Women in Charge: Meet Founder of Honest Hormones, Giada Bertola - Glamour S.A.

GLAMOUR Women in Charge: Meet Founder of Honest Hormones, Giada Bertola Glamour S.A.

Published: May 2, 2024, 7 a.m.
Former Liberal MP Nicolle Flint to recontest Adelaide seat of Boothby at next federal election - ABC News

Former Liberal MP Nicolle Flint to recontest Adelaide seat of Boothby at next federal election ABC News

Published: May 1, 2024, 7 a.m.
Former Tetbury mayor Ann Pearce admits falsely claiming benefits - BBC.com

Former Tetbury mayor Ann Pearce admits falsely claiming benefits BBC.com

Published: April 29, 2024, 7 a.m.
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting - PR Newswire

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting PR Newswire

Published: April 24, 2024, 7 a.m.
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting - Investor Relations | Karyopharm Therapeutics

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting Investor Relations | Karyopharm Therapeutics

Published: April 24, 2024, 7 a.m.
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses - Nature.com

Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses Nature.com

Published: April 23, 2024, 7 a.m.
Could this be a transformative year for women’s health? - Bill & Melinda Gates Foundation

Could this be a transformative year for women’s health? Bill & Melinda Gates Foundation

Published: April 17, 2024, 7 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!